SOPHiA Genetics officer sells shares for taxes
SOPHiA GENETICS SA Chief People Officer Manuela Valente reported an open-market sale of 3,824 Ordinary Shares on April 8, 2026 at a weighted average price of $4.849 per share.
Rhea-AI Filing Summary
SOPHiA GENETICS SA Chief People Officer Manuela Valente reported an open-market sale of 3,824 Ordinary Shares on April 8, 2026 at a weighted average price of $4.849 per share. According to the disclosure, the shares were sold to satisfy tax withholding obligations from restricted stock units that vested on April 2 and 3, 2026.
The filing states these sales were executed under a pre-established Rule 10b5-1 trading plan and are described as non-discretionary. After this transaction, Valente directly holds 215,451 Ordinary Shares of SOPHiA GENETICS SA.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 3,824 shares
Net Sell
1 txn
Insider
Valente Manuela
Role
Chief People Officer
Sold
3,824 shs ($19K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Ordinary Shares | 3,824 | $4.849 | $19K |
Holdings After Transaction:
Ordinary Shares — 215,451 shares (Direct)
Footnotes (2)
- F1. Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades.
- F2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.78 to $4.94, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Key Figures
Shares sold: 3,824 shares
Weighted average sale price: $4.849 per share
Post-transaction holdings: 215,451 shares
+2 more
5 metrics
Shares sold
3,824 shares
Open-market sale on April 8, 2026
Weighted average sale price
$4.849 per share
Ordinary Shares sold in multiple transactions
Post-transaction holdings
215,451 shares
Ordinary Shares beneficially owned after sale
Sale price range
$4.78–$4.94 per share
Range of transaction prices referenced in footnote
Net shares sold
3,824 shares
Net sell direction in transaction summary
Key Terms
Rule 10b5-1 trading plan, restricted stock units, weighted average price, beneficially owned
4 terms
Rule 10b5-1 trading plan financial
"These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
restricted stock units financial
"tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
weighted average price financial
"The price reported in Column 4 is a weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
beneficially owned financial
"total_shares_following_transaction": "215451.0000"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did SOPHiA GENETICS (SOPH) report for Manuela Valente?
SOPHiA GENETICS reported that Chief People Officer Manuela Valente sold 3,824 Ordinary Shares on April 8, 2026. The sale was in the open market at a weighted average price of $4.849 per share, as disclosed in a Form 4 filing.
Was the SOPHiA GENETICS (SOPH) insider sale made under a Rule 10b5-1 plan?
Yes. The filing states the sales were executed under a pre-established Rule 10b5-1 trading plan adopted by the reporting person. This indicates the trades were pre-planned and not timed at the insider’s discretion, reducing their informational significance.
AI-generated analysis. How Rhea-AI works. Not financial advice.
